Dr
Jessica
Kroeze

Patent Director

The Hague Office

Chemistry

Telephone. +31(0) 70 240 0899
Email. [email protected]

Experience

Jessica’s practice covers a wide range of inventions in the fields of materials science, physical chemistry, food technology, oil & gas, catalysis, and photovoltaics, and she is acting for a diverse range of companies across these technologies, from start-ups to multinationals.

She furthermore represents clients in Opposition and Appeal Proceedings before the European Patent Office.

Jessica also has experience in managing large IP portfolios, having spent several years working in-house for a multinational oil and gas company.

Before joining the patent profession in 2007, she worked as a researcher and university lecturer at Imperial College London and TU Eindhoven.

Jessica is qualified as a Dutch and European Patent Attorney (2010).

Qualifications

Patent Attorney

Dutch
European


MSCI

Physical-Organic Chemistry

PHD

Chemical Physics, Spectroscopy

OTHER

Praktika Interne Programme 2011, Board of Appeal, European Patent Office

CSR

Jessica has regularly acted as a tutor for Papers A and B of the European Qualification Examination (EQE), as well as for the Dutch Platform Formalities Officers.

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.